Correlation Between Merchant's Standard Q Angle and TT-TG Distance.|https://dx.doi.org/10.1177/23259671251397545
Characterization of a hypersporulating strain derivative of Clostridioides difficile R20291.|https://dx.doi.org/10.1101/2025.11.25.690273
Psychological predictors of CPAP therapy adherence in obstructive sleep apnea patients: insights from the predisposing, precipitating, and perpetuating factors model.|https://dx.doi.org/10.1016/j.ijchp.2025.100602
Inflammatory Bowel Disease, Gastrointestinal Graft-Versus-Host Disease and Immune Checkpoint Inhibitors Induced Colitis: Similar Diseases to Treat with Fecal Microbiota Transplantation.|https://dx.doi.org/10.3390/nu17233788
Evaluation of outcomes associated with antipseudomonal beta-lactams for treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort analysis.|https://dx.doi.org/10.1177/20499361251395527
Metabolic and pathogenic implications of sialic acid utilization in Clostridioides difficile infection.|https://dx.doi.org/10.1080/17460913.2025.2603859
Mycobacterium wolinskyi Bloodstream Infection Associated With a Central Venous Port: A Case Report.|https://dx.doi.org/10.7759/cureus.96872
Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient Monitoring.|https://dx.doi.org/10.1093/clinchem/hvaf156
Human C. difficile -specific memory B cells encode protective IgG1 despite predominance of non-neutralizing antibodies.|https://dx.doi.org/10.64898/2025.12.09.693127
Readmissions in Inflammatory Bowel Diseases: A Five-Year Retrospective Study in a Romanian Emergency County Hospital.|https://dx.doi.org/10.7759/cureus.97106
Awareness and perception of fecal microbiota transplantation in Lebanon: a cross-sectional survey among the general population, healthcare workers, physicians, and patients.|https://dx.doi.org/10.1177/17562848251399034
Unusual Development of Central Diabetes Insipidus after Endovascular Treatment for a Medial Tentorial Dural Arteriovenous Fistula.|https://dx.doi.org/10.5797/jnet.cr.2025-0106
The clinical significance of gut microbiota of chronic obstructive pulmonary disease with functional abdominal bloating and distension.|https://dx.doi.org/10.7717/peerj.20526
Challenges and Strategies in Managing Recurrent Clostridioides difficile Infection in Older Adults.|https://dx.doi.org/10.3390/geriatrics10060158
Fidaxomicin for Initial Episode of Clostridioides difficile Infection Reduces Recurrence in Immunocompromised Hosts-a Large Retrospective Cohort Study.|https://dx.doi.org/10.1093/ofid/ofaf751
Navigating recurrent Clostridioides difficile infection without Bezlotoxumab: potential challenges ahead.|https://dx.doi.org/10.1017/ash.2025.10144
Drug Development.|https://dx.doi.org/10.1002/alz70859_107684
Characterization of fecal deglucuronidation activity in healthy subjects and in patients treated with fecal microbiota transplantation.|https://dx.doi.org/10.1016/j.dmd.2025.100205
Combination Therapy with Oral Vancomycin Plus Intravenous Metronidazole Is Not Superior to Oral Vancomycin Alone for the Treatment of Severe Clostridioides difficile Infection: A KASID Multicenter Study.|https://dx.doi.org/10.3390/antibiotics14121252
Clostridioides difficile infection in Saudi Arabia: Prevalence, risk factors, and outcomes in a tertiary hospital setting.|https://dx.doi.org/10.1371/journal.pone.0340075
Bioinformatic and experimental identification and characterization of Clostridioides difficile lipoproteins as potential vaccine candidates.|https://dx.doi.org/10.3389/fimmu.2025.1650364
The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome.|https://dx.doi.org/10.1038/s41591-025-04076-w
Microbiome-selective DNA Pol IIIC inhibitors in oncology infection management.|https://dx.doi.org/10.1097/MS9.0000000000004423
